| Message: | Investigational New Drug (IND) is the key milestone prior to clinical testing on humans. Development of IND-enabling technologies is crucial for accelerate the discovery of new drugs and significantly reduce time to market and safety profile issues. If the application is cleared, the candidate drug usually enters the clinical trial stages.
Creative Biolabs offers comprehensive IND-enabling programs to assure that research subjects will not be subjected to unreasonable risks. Following the selection of clinical drug candidate criteria, we can help you with a number of preclinical IND-enabling studies and submitted the results in an IND application for approval to clinical phage trials. https://www.creative-biolabs.com/drug-discovery/therapeutics/ind-enabling-5.htm. |
my account
